| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 药品(元) | 1,117,443,103.25 | 1,757,747,768.26 | 1,134,652,158.91 | 3,043,785,611.77 |
| 医疗服务及健康管理(元) | 475,472,136.82 | 1,019,030,080.60 | 495,566,868.24 | 1,261,829,580.19 |
| 医疗器械(元) | 1,776,469,316.14 | 3,326,491,257.02 | 1,753,667,527.39 | 3,674,284,127.78 |
| 营业成本(元) | ||||
| 药品(元) | 416,209,441.72 | 813,026,692.22 | 453,638,509.26 | 952,895,286.39 |
| 医疗服务及健康管理(元) | 278,525,974.97 | 563,243,637.78 | 264,224,547.85 | 676,316,555.24 |
| 医疗器械(元) | 509,481,971.80 | 1,011,376,771.63 | 490,018,902.27 | 1,224,074,043.84 |
| 毛利(元) | ||||
| 药品(元) | 701,233,661.53 | 944,721,076.04 | 681,013,649.65 | 2,090,890,325.38 |
| 医疗服务及健康管理(元) | 196,946,161.85 | 455,786,442.82 | 231,342,320.39 | 585,513,024.95 |
| 医疗器械(元) | 1,266,987,344.34 | 2,315,114,485.39 | 1,263,648,625.12 | 2,450,210,083.94 |
| 毛利率(%) | ||||
| 药品(%) | 62.75 | 53.75 | 60.02 | 68.69 |
| 医疗服务及健康管理(%) | 41.42 | 44.73 | 46.68 | 46.40 |
| 医疗器械(%) | 71.32 | 69.60 | 72.06 | 66.69 |
| 收入构成(%) | ||||
| 药品(%) | 33.16 | 28.80 | 33.53 | 38.14 |
| 医疗服务及健康管理(%) | 14.11 | 16.70 | 14.64 | 15.81 |
| 医疗器械(%) | 52.72 | 54.50 | 51.82 | 46.04 |
| 毛利构成(%) | ||||
| 药品(%) | 32.39 | 25.43 | 31.30 | 40.79 |
| 医疗服务及健康管理(%) | 9.10 | 12.27 | 10.63 | 11.42 |
| 医疗器械(%) | 58.52 | 62.31 | 58.07 | 47.79 |